The research indicated that FOXO6 knockdown inhibited cell proliferation, migration, invasion and glycolysis of colorectal cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway (Li et al., 2019). The gene discussed is MTOR; the disease is colorectal cancer.